Auddia highlights Influence Healthcare's AI-powered, surgeon-led value-based care platform as it prepares to file S-4 merger registration. The model reduces administrativeAuddia highlights Influence Healthcare's AI-powered, surgeon-led value-based care platform as it prepares to file S-4 merger registration. The model reduces administrative

Auddia Highlights Influence Healthcare’s AI-Driven Surgeon-Led Model Ahead of Merger Filing

2026/05/12 18:06
4 min read
For feedback or concerns regarding this content, please contact us at [email protected]

Auddia Inc. (NASDAQ: AUUD) on Tuesday spotlighted Influence Healthcare, a healthtech company that uses artificial intelligence and vertical integration to enable surgeons to lead value-based care (VBC) in high-spend specialties. The announcement comes as Auddia prepares to file its Form S-4 with the Securities and Exchange Commission later this week, a key step in its planned merger with Thramann Holdings LLC.

Influence Healthcare is the third subsidiary, alongside LT350 and Voyex, that will become part of Auddia upon closing of the previously signed definitive merger agreement. The combined entity will be renamed McCarthy Finney, an AI holding company expected to trade under the ticker MCFN.

The company’s model is built on the premise that physicians should lead the healthcare system because they deliver the value. Influence Healthcare organizes surgeons into vertically integrated Value Based Enterprises (VBEs) that contract for bundled case-rate payments in spine, total joint, and other high-cost specialties. These VBEs are supported by advanced AI workflows that automate documentation, coding, episode validation, care-pathway coordination, staffing, supply chain, and logistics, allowing surgeons to focus on clinical care rather than administrative tasks.

“Healthcare is about a physician and patient entering into a relationship to optimize delivery of the highest quality care,” said Jeff Thramann, M.D., CEO of Auddia and Founder of Influence Healthcare, in a statement. “Only the physician has the knowledge, relationship with the patient, and clinical authority to make the many real-time decisions required to deliver the highest quality care at the lowest possible price. Influence Healthcare is aimed at leveraging AI to minimize administrative noise so that physicians and all the other healthcare professionals with hands on patients are empowered to deliver the highest value care.”

Influence Healthcare is intentionally designed as a structural alternative to hospital employment and private-equity rollups, which often reduce physician autonomy or prioritize financial engineering over clinical leadership. Instead, surgeon-led enterprises retain governance authority, episode-based economics flow to clinicians, and facilities participate through aligned partnerships rather than ownership. AI reduces overhead, and surgeons control the clinical pathway.

Post-merger, Influence Healthcare will leverage shared AI services from McCarthy Finney to deploy agentic-AI workflows that automate clinical documentation, coding and billing preparation, episode-of-care validation, prior-authorization workflows, care-pathway adherence monitoring, and communication across the episode. These workflows aim to eliminate administrative layers that have historically required multiple full-time administrative staff per surgeon, contributing to burnout and rising costs.

“AI should not replace physicians, it should replace the administrative friction that prevents physicians from practicing at the top of their license,” Dr. Thramann said. “Our platform gives surgeons the environment they need to deliver a more predictable, coordinated, efficient, and compassionate episode of care.”

The model is designed to deliver lower total cost of care through coordinated episodes, improved outcomes via surgeon-led pathway design, reduced administrative overhead through AI automation, predictable economics for payers and employers, and restored autonomy for surgeons. Influence Healthcare’s initial focus is on spine and total joint surgery, with plans to expand to additional specialties and markets through physician-led VBEs. More information is available at www.influencehealthcare.com.

The merger, announced on February 17, 2026, will combine Auddia with Thramann Holdings, which owns LT350, Influence Healthcare, and Voyex. Upon closing, Auddia will change its name to McCarthy Finney and trade under MCFN. The S-4 filing is expected later this week as the next step in the merger process.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by PRISM Mediawire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Auddia Highlights Influence Healthcare’s AI-Driven Surgeon-Led Model Ahead of Merger Filing.

The post Auddia Highlights Influence Healthcare’s AI-Driven Surgeon-Led Model Ahead of Merger Filing appeared first on citybuzz.

Market Opportunity
Gensyn Logo
Gensyn Price(AI)
$0.03265
$0.03265$0.03265
-10.37%
USD
Gensyn (AI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

KAIO Global Debut

KAIO Global DebutKAIO Global Debut

Enjoy 0-fee KAIO trading and tap into the RWA boom